PCVX (STOCKS)
Vaxcyte, Inc. Common Stock
$54.950000
-0.400000 (-0.72%)
Prev close: $55.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Grant E. Pickering
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,790.65M
- Employees
- 414
- P/E (TTM)
- -11.16
- P/B (TTM)
- 2.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.56 | $-1.29 | -0.2657 | -20.53% |
|
Jun 2025 (Q2)
|
$-1.22 | $-1.19 | -0.0251 | -2.10% |
|
Mar 2025 (Q1)
|
$-1.04 | $-1.07 | +0.0293 | +2.74% |
|
Dec 2024 (Q4)
|
$-1.01 | $-1.16 | +0.1504 | +12.92% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $811.56M |
| Research and Development | $685.86M |
| Other Operating Expenses | $118.70M |
| Operating Income/Loss | -$811.56M |
| Income/Loss From Continuing Operations After Tax | -$657.20M |
| Income/Loss From Continuing Operations Before Tax | -$657.20M |
| Net Income/Loss | -$657.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$657.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$657.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.84 |
| Diluted Earnings Per Share | -$4.84 |
| Basic Average Shares | 412,322,131 |
| Diluted Average Shares | 412,322,131 |
| Assets | $3.17B |
| Current Assets | $1.77B |
| Noncurrent Assets | $1.40B |
| Fixed Assets | $253.49M |
| Other Non-current Assets | $1.15B |
| Liabilities | $278.72M |
| Current Liabilities | $200.05M |
| Accounts Payable | $48.96M |
| Wages | $16.76M |
| Other Current Liabilities | $134.32M |
| Noncurrent Liabilities | $78.67M |
| Equity | $2.89B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.89B |
| Liabilities And Equity | $3.17B |
| Net Cash Flow From Operating Activities | -$542.15M |
| Net Cash Flow From Operating Activities, Continuing | -$542.15M |
| Net Cash Flow From Investing Activities | -$234.94M |
| Net Cash Flow From Investing Activities, Continuing | -$234.94M |
| Net Cash Flow From Financing Activities | $4.51M |
| Net Cash Flow From Financing Activities, Continuing | $4.51M |
| Exchange Gains/Losses | $3.61M |
| Net Cash Flow | -$768.96M |
| Net Cash Flow, Continuing | -$772.57M |
| Comprehensive Income/Loss | -$656.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$656.48M |
| Other Comprehensive Income/Loss | -$212.11M |
| Other Comprehensive Income/Loss Attributable To Parent | $717.00K |